Psoriasis, often misunderstood as merely a skin condition, is a complex immune-mediated disease impacting around 125 million individuals globally. This systemic condition demands comprehensive treatment strategies that go beyond addressing superficial skin symptoms. Dr. Graham Heap, Vice President
The notable effectiveness of clozapine in treating schizophrenia has placed it as the sole FDA-approved option for patients resistant to other treatments. However, despite its advantages, concerns have lingered due to studies suggesting a potential association between clozapine use and an increased
The pharmaceutical industry is undergoing a significant transformation driven by artificial intelligence (AI). This revolution is not just about improving processes but reshaping disease treatment and care delivery. Early adopters of AI in this sector are experiencing substantial gains,
The recent study conducted by the University of Bristol is bringing to light a promising crossover between wearable technology and health behavior change, especially focusing on aiding individuals in their quest to quit smoking. Led by Chris Stone and his dedicated team, the study employed
Over the past two decades, genetic research has made profound advancements, particularly in the collection and analysis of genomic data. This comprehensive data compilation includes invaluable genetic information from both modern populations and ancient lineages, offering unique opportunities to
Paul Simmonite, a 53-year-old deli owner from Keighley, has been battling aggressive bladder cancer. His journey through various treatments underscores both his resilience and the potential for groundbreaking advancements in cancer therapy. Diagnosed in August 2021 after noticing blood in his
